180 related articles for article (PubMed ID: 1327394)
21. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
22. Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo.
Persson MG; Gustafsson LE; Wiklund NP; Hedqvist P; Moncada S
Br J Pharmacol; 1990 Jul; 100(3):463-6. PubMed ID: 2390671
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide derived from L-arginine impairs cytoplasmic pH regulation by vacuolar-type H+ ATPases in peritoneal macrophages.
Swallow CJ; Grinstein S; Sudsbury RA; Rotstein OD
J Exp Med; 1991 Nov; 174(5):1009-21. PubMed ID: 1658185
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
Marsden PA; Ballermann BJ
J Exp Med; 1990 Dec; 172(6):1843-52. PubMed ID: 1979590
[TBL] [Abstract][Full Text] [Related]
25. Role of nitric oxide in control of prolactin release by the adenohypophysis.
Duvilanski BH; Zambruno C; Seilicovich A; Pisera D; Lasaga M; Diaz MC; Belova N; Rettori V; McCann SM
Proc Natl Acad Sci U S A; 1995 Jan; 92(1):170-4. PubMed ID: 7529411
[TBL] [Abstract][Full Text] [Related]
26. Induction of NG-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthases?
Bogle RG; MacAllister RJ; Whitley GS; Vallance P
Am J Physiol; 1995 Sep; 269(3 Pt 1):C750-6. PubMed ID: 7573406
[TBL] [Abstract][Full Text] [Related]
27. Vasomotor responses of canine coronary arterial rings to NG-monomethyl-L-arginine and N omega nitro L-arginine methyl ester.
Winn MJ; Asante NK; Ku DD
J Pharmacol Exp Ther; 1993 Jan; 264(1):265-70. PubMed ID: 8423529
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation.
Salvemini D; Masini E; Anggard E; Mannaioni PF; Vane J
Biochem Biophys Res Commun; 1990 Jun; 169(2):596-601. PubMed ID: 1972620
[TBL] [Abstract][Full Text] [Related]
29. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
McCall TB; Feelisch M; Palmer RM; Moncada S
Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
[TBL] [Abstract][Full Text] [Related]
30. Role of endothelium-derived nitric oxide in the regulation of blood pressure.
Rees DD; Palmer RM; Moncada S
Proc Natl Acad Sci U S A; 1989 May; 86(9):3375-8. PubMed ID: 2497467
[TBL] [Abstract][Full Text] [Related]
31. Effects of NG-substituted arginines on coronary vascular function after endotoxin.
Winn MJ; Vallet B; Asante NK; Curtis SE; Cain SM
J Appl Physiol (1985); 1993 Jul; 75(1):424-31. PubMed ID: 7690746
[TBL] [Abstract][Full Text] [Related]
32. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
Crack P; Cocks T
Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase.
Aguila MC
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):782-6. PubMed ID: 7904758
[TBL] [Abstract][Full Text] [Related]
34. L-NMMA in brain microcirculation of mice is inhibited by blockade of cyclooxygenase and by superoxide dismutase.
Rosenblum WI; Nishimura H; Nelson GH
Am J Physiol; 1992 May; 262(5 Pt 2):H1343-9. PubMed ID: 1590436
[TBL] [Abstract][Full Text] [Related]
35. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells.
Durante W; Schini VB; Scott-Burden T; Junquero DC; Kroll MH; Vanhoutte PM; Schafer AI
Am J Physiol; 1991 Dec; 261(6 Pt 2):H2024-30. PubMed ID: 1661096
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
Fedan JS; Warner TE; Yuan LX; Robinson Va; Frazer DG
J Pharmacol Exp Ther; 1995 Mar; 272(3):1141-50. PubMed ID: 7534351
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide enhances PGI(2)production by human pulmonary artery smooth muscle cells.
Wen F; Watanabe K; Yoshida M
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):369-78. PubMed ID: 10913230
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
[TBL] [Abstract][Full Text] [Related]
40. The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells.
Mollace V; Colasanti M; Muscoli C; Lauro GM; Iannone M; Rotiroti D; Nistico G
Br J Pharmacol; 1998 Jun; 124(4):742-6. PubMed ID: 9690866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
